Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2184)	1/22/2008 2:35:27 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

PFE Made a 2Yr L today as it traded below the $22 level, but is now still trying to stay above it.<g> stockcharts.com The new issue of B.W. has a 7 page article about the statins not doing any good for people with high cholesterol, with Lipitor on its front cover.It points out that for patients without heart disease, only one in 100 is likely to benefit from taking statins for years. The stock is trading around 2.15xBV with a +CF around $2.40 The short ratio came down 15% & is now about 1% of its ADV. To get off from its present NT DT the sock needs to close above $25.7 The more important support seems now at the Dec 2006 L of $20.27 Bernard

To: Jibacoa who wrote (2184)	2/4/2008 2:30:13 PM
From: Jibacoa	Respond to of 3722

INSM is up for 2nd day on a roll as it wants to try the resistance at the $0.88 level.<g> Volume is already > 551Ks. bigcharts.marketwatch.com On Jan 24 it gave an update on its IPLEX Expanded Access Program in Italy for the Treatment of ALS. It said that it received $5.2M in cost recovery from EAP for drug supplies in 2007. The EAP has now 15 physicians & > 70 subjects have been enrolled so far. IPLEX appears to have been safe and well tolerated & no individuals have dropped out for reasons related to IPLEX. INSM has reported triple digit improvements on revenues for the last 4 Qs & has been able to trim its losses.The EL for 2007 is around $0.20/shr vs. the $0.58 loss in 2006 & for 2008 the EL is around $0.15/shr The short ratio went up 15% in the last month & is now around 5x its ADV. The stock needs to close above its Jan 3 H of $0.92 in order to get off from its near term DT.Its longer term DT comes from the Jan 2006 H at $3.25 The Sep 2000 H was $19.60 <g> bigcharts.marketwatch.com Bernard